SEARCH Advanced Search
T. Jake Liang, MDChief, Liver Diseases BranchChief, Clinical SectionNational Institute of Diabetes and Digestive and Kidney Diseases National Institutes of HealthBldg.10, Rm: 9B06Bethesda, Maryland 20892jakel@mail.nih.gov
T. Jake Liang, M.D. Nursing and Ancillary Staff Attending Staff Clinical Research Protocols Current Fellows Patient Information Hepatology Fellowship Program # Protocol Title Clinical Trials.gov Identifier 1 1991-DK-0214 Evaluation of Patients with Liver Disease NCT00001971 2 2000-DK-0125 Immunogenetics of Hepatitis C virus infection NCT00005657 3 2000-DK-0186 The Hep C Antiviral Long-Term Tx Against Cirrhosis (HALT-C) Trial: A Randomized Controlled Trial to Evaluate the Safety & Efficacy of Long-Term Peginterferon Alpha2A for Tx of Chronic Hep C in Patients Who Failed to Respond to Previous Interferon Therapy NCT00006164 4 2000-DK-0221 Evaluation of the Immune Response in Humans After Exposure to Hepatitis C Virus NCT00006301 5 2001-DK-0246 Combination of Lamivudine and Adefovir Dipivoxil for Treatment of Chronic Hepatitis B NCT00023309 6 2001-DK-0247 Treatment of Chronic Delta Hepatitis with Pegylated Interferon NCT00023322 7 2002-DK-0065 Combination of Pegylated Interferon and Ribavirin as Therapy for Patients with Chronic Hepatitis C with and without Renal Disease NCT00028093 8 2003-DK-0136 Low dose Peginterferon and Ribavirin therapy for patients with chronic hepatitis C infected with genotype 2 or 3 NCT00056862 9 2007-DK-0143 Effects of S-Adenosyl Methionine (SAMe) on viral and cell signaling response to combination therapy for chronic hepatitis C NCT00475176 10 2007-DK-0207 Tenofovir Disoproxil Fumarate Alone Versus its Combination with Emtricitabine for Treatment of Chronic Hepatitis B NCT00524173 11 2008-DK-0106 Hepatitis C Eradication and Progression of Atherosclerosis NCT00659256 12 2008-DK-0149 High Dose Ribavirin in Combination with Peginterferon for Patients with Chronic Hepatitis C Genotype 1 Infection Who Have Failed to Respond or Relapsed after Standard Therapy NCT00735969 13 2008-DK-0182 Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C NCT00718172 14 2009-DK-0067 Long-Term Follow-Up of HALT-C Sustained Virologic Responders NCT00825877 15 2010-DK-0187 Duration of Long-Term Immunity After Hepatitis B Virus Immunization NCT01182311 16 2011-DK-0108 Observational Study of Persons with Hepatitis B Virus Infection in North America (Cohort Study) NCT01306071 17 2011-DK-0151 Withdrawal of Therapy After Long-Term Oral Nucleos(t)ide Analogue Treatment in Patients with Chronic Hepatitis B 18 2012-DK-0046 Treatment of Chronic Delta Hepatitis with Lonafarnib NCT01495585
Page last updated: January 24, 2012
